Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S2W-08104 · Session 2

Further to the answer to question S2W-7038 by Malcolm Chisholm on 1 April 2004, whether it will list all cases where thiomersal has been re…

Answered Asked by Carolyn Leckie SSP Lodged 7 May 2004

The question

To ask the Scottish Executive, further to the answer to question S2W-7038 by Malcolm Chisholm on 1 April 2004, whether it will list all cases where thiomersal has been removed from vaccines as a precautionary measure.

The answer

Answered by Malcolm Chisholm on 21 May 2004 · 14 days after it was lodged, on time

The regulation and safety ofmedicines is reserved and is the responsibility of the Medicines and Healthcareproducts Regulatory Agency (MHRA). The MHRA has advised that since October 2003the following vaccines have had thiomersal removed from the manufacturing formulationof the bulk vaccine and consequently the finished products:
Tetavax
- adsorbed Tetanus Vaccine;
Diftavax
- adsorbed Diphtheriaand Tetanus Vaccine for adults and adolescents;
Influvac
- influenza vaccine,surface antigen, inactivated, and
Mastaflu
- influenza vaccine,surface antigen, inactivated.
Thiomersal is not used in themanufacturing process therefore these vaccines do not contain a manufacturing residue.

In the Official Report

No contribution in the Official Report cites S2W-08104 by reference.